MEGAN GODOY: Open Payments
NPI 1710743067 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $61 |
| Exact Sciences Corporation | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| SANOFI PASTEUR INC. | 2 | $41 |
| Dynavax Technologies Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $15 |
Products named: REXULTI, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, The Cologuard Plus Collection Kit, Heplisav-B, JARDIANCE, MOUNJARO, Wegovy, TZIELD.
Industry payments across CA — which companies pay providers there.
